« Return to News | Awards & Advancement

HemoShear appoints Figler scientific director

Monday, February 6, 2012 02:50 PM

HemoShear, a biotechnology research company, has appointed Robert A. Figler, Ph.D., scientific director.

Previously, Figler was director of pharmacology at Adenosine Therapeutics and an assistant professor in the department of molecular physiology and biological physics at the University of Virginia (UVA). He is also a well-published scientist who is a named inventor on seven patents for adenosine analogs, several of which are in human clinical trials. Figler has extensive experience with animal models and in-vitro assays used in drug development.

Figler's primary responsibility will be to lead HemoShear's NIH-funded research efforts to develop an extensive database of drug-induced vascular genomic response profiles using the company's proprietary human-surrogate vascular system.

"HemoShear's business is growing and our needs for additional scientific and operational expertise are increasing," said Jim Powers, HemoShear's CEO. 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.